NIC

A hands-on workshop on 4D-Nucleofector technology provided insights into gene transfer using Lonza’s Core- and X units. Participants learned about nucleofection, optimized protocols, and best practices for efficient gene delivery in cell-based research.

Imagine a world where a child’s genetic disorder, once considered untreatable, is finally on a path toward real solutions. For families affected by the CTNNB1 syndrome, that future is becoming a reality thanks to ...

Research on combining cytokines and pyroptosis for cancer therapy by Slovenian scientists has gained significant media recognition, including TV features, articles, and the honor of being named "Names of the Week".

CTGCT welcomes Slovenia's entry into the European Research Partnership for Rare Diseases ERDERA

Check this video were he Head of the #CTGCT prof. dr. Mojca Benčina appeared in the news of the Slovenian national TV since her researched was selected as one of the breakthrough discoveries by ...

We are pleased to share that our latest paper has been accepted for publication in the Computational and Structural Biotechnology Journal (CSBJ)

From the 16th of October 2024 to the 18th the Kemijski Inštitut hosted the 1st CTGCT Conference

Translational Medicine Ecosystem Ljubljana, Slovenia, Friday 18th October 2024, Location: Kemijski inštitut online transmission of event: webex teleconferencing link   8:30 Registration 9:00 Welcome Addresses Gregor Anderluh, National Institute of Chemistry Mojca Benčina, CTGCT ...

The CTGCT hosted representatives from ERN ITHACA and SATB2 Europe to discuss collaborative efforts in rare disease research and treatment. The meeting focused on developing innovative therapies and strengthening connections between researchers, clinicians, and ...